VSee Health (NASDAQ:VSEE) has received approval from Nasdaq to maintain its listing status, subject to specific conditions. The company must file its delayed Q1 and Q2 2025 quarterly reports by October 15, 2025, and demonstrate compliance with Nasdaq's Equity Rule by December 1, 2025.
The company is actively working with its auditors to complete and submit the required financial reports within the extension period granted by the Nasdaq Hearings Panel. Additionally, VSee Health has confirmed its commitment to addressing and meeting the net equity requirements within the specified timeframe.
VSee Health (NASDAQ:VSEE) ha ottenuto l'approvazione da Nasdaq per mantenere lo status di quotazione, soggetta a particolari condizioni. La società deve presentare entro il 15 ottobre 2025 i propri rapporti trimestrali posticipati del Q1 e Q2 2025 e dimostrare di rispettare la Equity Rule di Nasdaq entro il 1 dicembre 2025. L'azienda sta collaborando attivamente con i propri revisori per completare e inviare i rapporti finanziari richiesti entro il periodo di estensione concesso dal Nasdaq Hearings Panel. Inoltre, VSee Health ha confermato l'impegno a soddisfare i requisiti di patrimonio netto entro il termine previsto.
VSee Health (NASDAQ:VSEE) ha recibido la aprobación de Nasdaq para mantener su estatus de cotización, sujeto a condiciones específicas. La compañía debe presentar sus informes trimestrales pendientes del Q1 y Q2 2025 antes del 15 de octubre de 2025 y demostrar cumplimiento con la Regla de Capital de Nasdaq para el 1 de diciembre de 2025. La empresa está trabajando activamente con sus auditores para completar y presentar los informes financieros requeridos dentro del período de prórroga otorgado por el Panel de Audiencias de Nasdaq. Además, VSee Health ha confirmado su compromiso de cumplir con los requisitos de patrimonio neto dentro del plazo especificado.
VSee Health(NASDAQ:VSEE)는 특정 조건에 따라 상장 상태를 유지할 수 있는 Nasdaq의 승인을 받았습니다. 회사는 2025년 1분기 및 2분기 분기보고서를 2025년 10월 15일까지 제출하고 2025년 12월 1일까지 Nasdaq의 자본 규정(Equity Rule)을 준수하는 것을 입증해야 합니다. 회사는 Nasdaq 청문 패널이 부여한 연장 기간 내에 필요한 재무 보고서를 완료 제출하기 위해 감사인과 적극적으로 협력하고 있습니다. 또한 VSee Health는 지정된 기간 내에 순자본 요건을 충족하겠다는 약속을 확인했습니다.
VSee Health (NASDAQ:VSEE) a obtenu l'approbation de Nasdaq pour maintenir son statut de cotation, sous réserve de certaines conditions. La société doit déposer ses rapports trimestriels retardés du Q1 et Q2 2025 d'ici le 15 octobre 2025 et démontrer sa conformité à la règle des fonds propres de Nasdaq d'ici le 1er décembre 2025. L'entreprise travaille activement avec ses auditeurs pour compléter et soumettre les rapports financiers requis dans la période de prolongation accordée par le Panel d'audiences de Nasdaq. De plus, VSee Health a confirmé son engagement à satisfaire les exigences de fonds propres nets dans le délai indiqué.
VSee Health (NASDAQ:VSEE) hat von Nasdaq die Genehmigung erhalten, den Börsenlisting unter bestimmten Bedingungen fortzuführen. Das Unternehmen muss seine verspäteten Q1- und Q2-2025 Quartalsberichte bis zum 15. Oktober 2025 einreichen und die Einhaltung der Nasdaq-Eigenkapitalregel bis zum 1. Dezember 2025 nachweisen. Das Unternehmen arbeitet eng mit seinen Prüfern zusammen, um die erforderlichen Finanzberichte innerhalb des von der Nasdaq Hearings Panel gewährten Verlängerungszeitraums abzuschließen und einzureichen. Darüber hinaus hat VSee Health bestätigt, sich innerhalb des festgelegten Zeitrahmens verpflichtet zu haben, die Netto-Eigenkapitalanforderungen zu erfüllen.
حصلت VSee Health (ناسداك: VSEE) على موافقة ناسداك للحفاظ على وضعها كشركة مدرجة، مع اشتراطات محددة. يجب على الشركة تقديم تقاريرها الربع سنوية المأخرة للربعين الأول والثاني من 2025 بحلول 15 أكتوبر 2025 وإثبات الامتثال لقواعد حقوق الملكية لدى ناسداك بحلول 1 ديسمبر 2025. تعمل الشركة بنشاط مع مدققيها لإكمال وتقديم التقارير المالية المطلوبة ضمن فترة التمديد التي منحها مجلس الاستماع في ناسداك. بالإضافة إلى ذلك، أكدت VSee Health التزامها بالوفاء بمتطلبات حقوق الملكية الصافية ضمن الإطار الزمني المحدد.
VSee Health（纳斯达克股票代码：VSEE）已获纳斯达克批准维持上市地位，需满足特定条件。公司须在2025年10月15日前提交其延迟的2025年第一季度和第二季度季度报告，并在2025年12月1日前证明符合纳斯达克的股本规则。公司正与审计师积极合作，在纳斯达克听证小组给予的延期期间内完成并提交所需的财务报告。此外，VSee Health 已确认其承诺在指定时间内满足净股本要求。
Positive
Secured continued Nasdaq listing approval
Received extension period to file delayed reports
Given time until December 1, 2025 to meet equity requirements
Negative
Company has failed to file Q1 and Q2 2025 quarterly reports
Currently not compliant with Nasdaq's Equity Rule
Risk of delisting if compliance requirements are not met by deadlines
SAN JOSE, CA / ACCESS Newswire / September 24, 2025 / VSee Health, Inc. (Nasdaq: VSEE) (the "Company"), a provider of comprehensive telehealth services that customizes telehealth work-flow streams and enhances patient care, today announced that the Company was notified by The Nasdaq Stock Market LLC ("Nasdaq") in a letter dated September 15, 2025, that the Nasdaq Hearings Panel (the "Panel") had granted the Company's request for continued listing on Nasdaq, subject to the Company (i) evidencing compliance with Nasdaq's periodic reporting requirement by filing its Q1 and Q2 Quarterly report ending March 31, 2025 and June 30, 2025 respectively (together, the "Delayed Reports") on Form 10-Q by October 15, and (ii) demonstrating compliance with the Equity Rule by December 1, 2025.
The Company continues to work diligently with its auditor to complete and file the Delayed Reports and expects to do so within the extension period granted by the Panel. The company also plans to address and meet the net equity requirements within the extension period.
About VSee Health
VSee Health (Nasdaq: VSEE) is a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by 1,000+ clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSee Health provides foundational infrastructure for digital healthcare and delivers turnkey solutions including critical care, teleradiology, and autonomous robotics to optimize healthcare operations while increasing billable patient visits and provider efficiency. Visit vseehealth.com.
Forward-Looking Statements
Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
What conditions did Nasdaq set for VSee Health (VSEE) to maintain its listing?
Nasdaq requires VSee Health to file Q1 and Q2 2025 quarterly reports by October 15, 2025, and demonstrate compliance with the Equity Rule by December 1, 2025.
When must VSee Health (VSEE) file its delayed quarterly reports?
VSee Health must file its Q1 and Q2 2025 quarterly reports by October 15, 2025.
What happens if VSee Health (VSEE) fails to meet Nasdaq's requirements?
If VSee Health fails to meet the filing deadline and equity requirements by the specified dates, the company could face potential delisting from Nasdaq.
What is the deadline for VSee Health (VSEE) to comply with Nasdaq's Equity Rule?
VSee Health must demonstrate compliance with Nasdaq's Equity Rule by December 1, 2025.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, to receive support.
